São Paulo, Brazil

Jivaldo Matos



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jivaldo Matos: Innovator in Immunogenical Complexes

Introduction

Jivaldo Matos is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of immunology through his innovative work on immunogenical complexes. His research focuses on enhancing the efficacy of vaccines by utilizing advanced materials.

Latest Patents

Jivaldo Matos holds a patent for an "Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica." This invention relates to a product that comprises an adjuvant characterized by solid particles of highly ordered nanostructured mesoporous silica, specifically SBA-15 Silica, along with various vaccinal antigens encapsulated within these adjuvants. The immunogenical complex allows for the safe, gradual, and extended presentation of antigens to lymphocytes, leading to improved immunological memory and increased immunogenicity. This innovation ensures effective immunological protection with reduced amounts of antigens and fewer vaccine doses.

Career Highlights

Throughout his career, Jivaldo Matos has worked with prominent companies, including Cristalia Produtos Quimicos Farmaceuticos Ltda. and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). His work has been instrumental in advancing vaccine technology and improving public health outcomes.

Collaborations

Jivaldo has collaborated with esteemed colleagues such as Ogari Pacheco and Osvaldo Augusto Sant'Anna. These partnerships have contributed to the success of his research and the development of innovative solutions in immunology.

Conclusion

Jivaldo Matos is a pioneering inventor whose work on immunogenical complexes has the potential to revolutionize vaccine efficacy. His contributions to the field of immunology are significant and continue to impact public health positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…